Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
F-18-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials
F-18-Labeled Peptides: The Future Is Bright
F-18-fluoride PET/CT for bone scanning Role of attenuation correction
F-18-FDG-PET-CT in soft tissue sarcomas: When to image?
F-18-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
F-18-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
F-18-FDG Uptake to Assess Eosinophilic Inflammation in Asthma: Would SUV at Late Imaging Be Relevant?
F-18-FDG PET Imaging of Murine Atherosclerosis: Association with Gene Expression of Key Molecular Markers
F-18-FDOPA PET for the diagnosis of parkinsonian syndromes
F-18-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma
F-18 Fluorodeoxyglocose Positron Emission Tomography/Computed Tomography in the Diagnosis of Chronic Myopathic Sarcoidosis
F-18-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
F-18-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells
F-18-labelling of a cyclic pentapeptide inhibitor of the chemokine receptor CXCR4
F-18-FDG PET in the Evaluation of Acuity of Deep Vein Thrombosis
F-18-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study
F-18-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
F-18-Labelled Intermediates for Radiosynthesis by Modular Build-Up Reactions: Newer Developments
F-18-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response
F-18-labelled CCR1-receptor antagonist is not suitable for imaging of Alzheimer's disease
F-18-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
F-18-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
F-18-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer
F-18-FDG-PET/CT in fever of unknown origin: clinical value
F-18-FDG uptake in reactive neck lymph nodes of oral cancer: Relationship to lymphoid follicles
F-18-FDG PET/MRI Can Be Used to Identify Injured Peripheral Nerves in a Model of Neuropathic Pain
F-18 FDG PET/CT Contributes to More Accurate Detection of Lymph Nodal Metastasis From Actively Proliferating Esophageal Squamous Cell Carcinoma
F-18 FDG PET/CT Findings of Aggressive NK-Cell Leukemia
F-18-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group
F-18-Fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts
F-18-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling With Hexadecyl-4-[F-18]Fluorobenzoate for In Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography
F-18-FDG PET/CT Imaging In Oncology
F-18-Labeled Phenyldiazenyl Benzothiazole for in Vivo Imaging of Neurofibrillary Tangles in Alzheimer's Disease Brains
F-18-FLT and F-18-FDOPA PET kinetics in recurrent brain tumors
F-18-Labeled-Bioorthogonal Liposomes for In Vivo Targeting
F-18-FDG PET/CT imaging of massive portal vein tumor thrombosis from ileal adenocarcinoma
F-18-FDG PET/CT Imaging Detects Therapy Efficacy of Anti-EMMPRIN Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts
F-18-FDG PET/CT Imaging for an Early Assessment of Response to Sunitinib in Metastatic Renal Carcinoma: Preliminary Study
F-18-FDG-PET/CT in lymphoma: Two decades of experience
F-18-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
F-18-FDG PET/CT of Cervical Carcinoma
F-18-FDG Imaging of Carotid Arteries for Identifying the Vulnerable Patient: Are We at the Beginning of the End?
F-18-Fluorodeoxyglucose-Positron Emission Tomography Scanning Is More Useful in Followup Than in the Initial Assessment of Patients With Erdheim-Chester Disease
F-18-FDG PET/CT Useful for the Early Detection of Rapidly Progressive Fatal Interstitial Lung Disease in Dermatomyositis
F-18-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons
F-18-FDG and FDG-Labeled Leukocyte PET/CT in Peritoneal Tuberculosis
F-18-FDG PET in Pregnancy and Fetal Radiation Dose Estimates
F-18-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors
F-18 Labeling Protocol of Peptides Based on Chemically Orthogonal Strain-Promoted Cycloaddition under Physiologically Friendly Reaction Conditions
F-18-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging
F-18-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
F-18-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum
F-18-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach
F-18-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma